TheEdgeResearch
Home / Stocks / MVF.AX

Monash IVF Group Limited (MVF.AX)

ASX Healthcare Medical - Diagnostics & Research
$0.70 ▲ +0.72%
Market Cap
$272.7M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.39
52-Wk Range
0.575-0.895
CEO
Victoria Atkinson Afracma Fracs Mbbs
Country
AU
Currency
AUD

Monash IVF Group Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Richmond, VIC, AU. The stock last traded at $0.70, up 0.72% on the session, giving a market capitalisation of $272.7M. Its beta of 0.39 implies it has historically moved less than the broad market.

Company profile
Exchange
Australian Securities Exchange
Employees
892
IPO date
2014-06-26
Headquarters
Richmond, VIC, AU
About Monash IVF Group Limited

Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.

Comparable companies

Monash IVF Group Limited is most often compared with the following Healthcare names:

AFP.AXARX.AXAVR.AXBOT.AXDXB.AXIMR.AXLDX.AXOCC.AXPEB.AXTTX.AX
More research on MVF.AX
MVF.AX technical analysis MVF.AX TheEdge Score Compare against peers
Open full interactive analysis & DCF →